Zhiming Zhou

Dr. Zhiming Zhou


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Interventional Neurology
Verified
Journal Article
Closed access
PDF file
HXHuang Xianjun
Huang Xianjun
ZZZhiming Zhou
Zhiming Zhou
Background: We conducted a review of the safety and outcomes of endovascular intervention in patients with internal carotid artery dissection (ICAD). Summary: A literature review was performed. PubMed and Medline databases were searched from inception to September 2012 with the key words ‘carotid artery' (title), ‘dissection' (title) and ‘endovascular' (title/abstract). All studies were included which reported outcomes of endovascular intervention in ICAD and provided information about technical and clinical results. After screening, we included 23 articles. In total, 201 patients (128 male and 73 female) were included in the eligible studies. The mean age was 46.7 years (range 13-83 years). Of the 201 patients, the causes of the carotid dissections were traumatic in 69 (34.3%), spontaneous in 115 (57.2%) and iatrogenic in 17 (8.5%). The technical success rate was 99.1%. The overall rate of major cardiovascular events in the perioperative period was 4%. No procedure-related deaths occurred. Imaging follow-up data (mean follow-up time 16.5 months) demonstrated that only 3.3% of patients had intimal hyperplasia or in-stent restenosis or occlusion of a treated vessel. Clinical follow-up data (mean follow-up period 20.9 months) showed that only 2.1% of patients had a recurrent transient ischemic attack in the territory of the treated vessel. Key Messages: Endovascular intervention with stenting or stent-graft-supported angioplasty in selected patients with ICAD is promising. However, further evaluation is warranted to provide more evidence to support the feasibility of endovascular procedures in treating ICAD.

1 January 2019 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
LWling Wang
ling Wang
ZZZhiming Zhou
Zhiming Zhou
XTXiguang Tian
Xiguang Tian
HWHuaiming Wang
Huaiming Wang
DYDong Yang
Dong Yang
XLXinfeng Liu
Xinfeng Liu

1 January 2021 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
QWQi Wang
Qi Wang
LYLili Yuan
Lili Yuan
XDXianhui Ding
Xianhui Ding
ZZZhiming Zhou
Zhiming Zhou
Venous thromboembolism (VTE) is a fatal disease and has become a burden on the global health system. Recent studies have suggested that artificial intelligence (AI) could be used to make a diagnosis and predict venous thrombosis more accurately. Thus, we performed a meta-analysis to better evaluate the performance of AI in the prediction and diagnosis of venous thrombosis. PubMed, Web of Science, and EMBASE were used to identify relevant studies. Of the 741 studies, 12 met the inclusion criteria and were included in the meta-analysis. Among them, 5 studies included a training set and test set, and 7 studies included only a training set. In the training set, the pooled sensitivity was 0.87 (95% CI 0.79-0.92), the pooled specificity was 0.95 (95% CI 0.89-0.97), and the area under the summary receiver operating characteristic (SROC) curve was 0.97 (95% CI 0.95-0.98). In the test set, the pooled sensitivity was 0.87 (95% CI 0.74-0.93), the pooled specificity was 0.96 (95% CI 0.79-0.99), and the area under the SROC curve was 0.98 (95% CI 0.97-0.99). The combined results remained significant in the subgroup analyzes, which included venous thrombosis type, AI type, model type (diagnosis/prediction), and whether the period was perioperative. In conclusion, AI may aid in the diagnosis and prediction of venous thrombosis, demonstrating high sensitivity, specificity and area under the SROC curve values. Thus, AI has important clinical value.

1 January 2021 in Therapeutic Advances in Neurological Disorders
Verified
Journal Article
Open access
PDF file
XHXianjun Huang
Xianjun Huang
HGHongquan Guo
Hongquan Guo
LYLili Yuan
Lili Yuan
QCQiankun Cai
Qiankun Cai
MZMin Zhang
Min Zhang
XLXinfeng Liu
Xinfeng Liu
Blood pressure (BP), recanalization status, and collateral circulation are important factors for cerebral autoregulation after stroke. We aimed to investigate the association of various BP variability (BPV) parameters with clinical outcomes after mechanical thrombectomy (MT) according to recanalization and collateral status. We included 502 consecutive patients who underwent MT due to anterior circulation large vessel occlusion stroke at three comprehensive stroke centers. BPV parameters were standard deviation (SD), maximum/minimum BP, coefficient of variation (CV) and successive variation (SV). The clinical outcomes included 90-day functional outcome assessed by modified Rankin Scale score and symptomatic intracranial hemorrhage (sICH). Among the included patients, 219 (43.6%) achieved good functional outcomes and 59 (11.8%) developed sICH. After adjusting for confounders, higher systolic BP (SBP) variability [CV (odds ratio (OR), 1.089, p = 0.035), SV (OR, 1.082, p = 0.004). and SD (OR, 1.074, p = 0.027)] was associated with a lower likelihood of a favorable outcome. In addition, higher SBP [CV (OR, 1.156, p = 0.001) and SD (OR, 1.118, p = 0.001)] were significantly associated with increased odds of sICH. Moreover, the relationship between BPV and the outcomes depended on recanalization status. However, regardless of collateral status, a higher BPV after MT was associated with worse outcomes. Higher SBP SD and CV during the first 24 h after MT was a powerful predictor of worse clinical outcomes, regardless of the collateral status. However, the effects of BPV on outcomes were more substantial among patients with successful reperfusion.

29 July 2021 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Open access
PDF file
ZRZeguang Ren
Zeguang Ren
XHXiaochuan Huo
Xiaochuan Huo
GMGaoting Ma
Gaoting Ma
XTXu Tong
Xu Tong
JKJay Kumar
Jay Kumar
ZMZhongrong Miao
Zhongrong Miao

5 July 2019 in BMC Neurology
Verified
Journal Article
Open access
PDF file
XSXian-Jin Shang
Xian-Jin Shang
ZSZhong-Hua Shi
Zhong-Hua Shi
CHCai-Feng He
Cai-Feng He
SZShuai Zhang
Shuai Zhang
YBYongjie Bai
Yongjie Bai
XLXinfeng Liu
Xinfeng Liu
Mechanical thrombectomy has been proven as a standard care for moderate to severe ischemic stroke with anterior large vessel occlusion (LVO); however, whether it is equally effective in mild ischemic stroke (MIS) is controversial. In this retrospective study, a total of 177 Chinese patients presenting with MIS (NIHSS ≤8) and LVO between January 2014 and September 2017 from seven comprehensive stroke centers were identified. Odds of good outcome with endovascular thrombectomy versus medical treatment were obtained by logistic regression analysis and propensity-score matching method, and a meta-analysis pooled results from six studies (n = 733). Good outcome (mRS: 0–1) was 58.2% (46/79) in the thrombectomy and 46.9% (46/98) in the medical group, which showed no statistical significance before adjustment (P = 0.13; OR = 1.57, 95% CI: 0.86 to 2.86). The adjusted ORs of thrombectomy versus medical group were 3.23 (95% CI, 1.35 to 7.73; P = 0.008) by multivariable logistic analysis, 2.78 (1.12 to 6.89; P = 0.02) by propensity score matching analysis, and 3.20 (1.22 to 8.37; P = 0.01) by propensity score matching analysis with additional adjustments, respectively. Thrombectomy treatment did not result in excessive mortality or symptomatic intracranial hemorrhage after adjustments. The meta-analysis did not confirm the associations between good outcome and endovascular treatment. The current study indicates that endovascular thrombectomy is associated with good functional outcome in MIS patients with LVO, and without additional risk of symptomatic intracranial hemorrhage and mortality. Although the meta-analysis failed to demonstrate its superiority compared to medical treatment, randomized clinical trials are needed.